49527-715 NDC - SKIN SUPPLIES FOR MEN ANTIPERSPIRANT ()

Drug Information

  • Product NDC: 49527-715
  • Proprietary Name: Skin Supplies for Men antiperspirant
  • Non Proprietary Name:
  • Active Ingredient(s):
  • Administration Route(s):
  • Dosage Form(s):

Labeler Information

Field Name Field Value
Labeler Name: CLINIQUE LABORATORIES INC
Product Type:
FDA Application Number: part350
Marketing Category: OTC MONOGRAPH FINAL
Start Marketing Date:2/23/2012

Package Information

No. Package Code Package Description Billing Unit
149527-715-0175 mL in 1 CYLINDER (49527-715-01)

NDC Record

Field Name Field Value Definition
PRODUCT NDC49527-715The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMESkin Supplies for Men antiperspirantThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
PROPRIETARY NAME SUFFIXCliniqueA suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard.
START MARKETING DATE2/23/2012The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
MARKETING CATEGORY NAMEOTC MONOGRAPH FINALThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
APPLICATION NUMBERpart350This is the date that the labeler indicates was the start of its marketing of the drug product.
LABELER NAMECLINIQUE LABORATORIES INCThis is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 11/21/2025

Previous Code
Next Code